Home
ContourMD
Contact Us
Shopping Cart
Advanced search  
  
    Bath and Safety
    Batteries
    Diabetic
    Enteral & Oral Feeding
    General Nursing
    Incontinence
    Infant and Youth
    Infusion Therapy
    Ostomy
    OTC Drugs
    Preventive Care
    Rehabilitation
    Respiratory
    Skin Integrity
    Urologicals
    Walkers
    Wound

  
Select Medical
ROCHE DIAG
BECTON DICKINSO
HYPOGUARD / ARKRAY
OWEN MUMFORD
ACP MEDICAL INC
KENDALL
MEDICAL ACTION
GOJO INDUSTRIES, INC
HUDSON

Other manufacturers...


  
Gift certificates


  
Contact us
Coupons
Privacy Statement
Terms & Conditions
About Our Site

 


» Medical SupplyBiz » Profile details

Create Profile

The form below allows you to create a profile which is necessary to place orders. Do not forget that this information is essential to use our services correctly.

The fields marked with * are mandatory.


  Profile details
Personal information
Title *
First Name *
Last Name *
Company  
Tax number  
Billing Address
Address *
Address (line 2)  
City *
County *
State *
Country *
Zip/Postal code *

 


Address  
Address (line 2)  
City  
County *
State  
Country  
Zip/Postal code  
Contact Information
Phone Number *
E-Mail *
Fax  
Web site  
Username & Password
Membership
Username *
Password *
Confirm Password *
Newsletter
If you wish to receive our Newsletter, please select the News lists to which you want to subscribe:
 
Health Care Bill Inches Forward
  Health Bill Inches Forward In House By ERICA WERNER, AP July 30, 2009 WASHINGTON -House Democrats methodically pushed ahead with a compromise health overhaul Thursday over liberals' complaints, intent on achieving tangible — if modest — success on President Barack Obama's top domestic priority ahead of a monthlong summer recess. "We've got to pass the bill. Not only do we have to, but we're going to," said Rep. Henry Waxman, D-Calif., chairman of the Energy and Commerce Committee, the last of three House committees to act on the sweeping legislation. Across the Capitol, there was more delay as bipartisan Senate negotiators announced they needed additional time to produce any agreement for their committee to review. Sen. Max Baucus, D-Mont., chairman on the Finance Committee, said it would be September before the panel could act. He spoke after a day of uncertainty in which months of negotiations briefly appeared to veer off-course. "The president, Leader (Harry) Reid and I share the goal of a bipartisan bill and we will continue to work toward meaningful, bipartisan legislation that can pass the Senate and become law this year," Baucus said in a statement. Sen. Charles Grassley of Iowa, the lead Republican in the talks, said earlier that the discussions have made very good progress and may result in a deal. "But that'll never happen if Democrat leaders tell Republicans to take a hike by forcing the committee to move on an all-Democrat bill," he said. Reid told reporters during the day that August deadlines were a product of the media, rather than lawmakers or the White House. Republicans swiftly produced a rebuttal, in the form of statements from Obama as well as Reid underscoring the importance of action by early August. Both chambers already had jettisoned plans for floor votes before the summer break, but Democrats had hoped to get bills out of the final House and Senate committees that had yet to act. That would have allowed Democrats to show clear momentum when they returned to their home districts and states in August, so the news out of the Senate Finance Committee was a setback. But in the House Waxman's committee resumed work Thursday, with the goal of finishing Friday, after a week-and-a-half delay caused by objections from fiscally conservative Democrats. That rebellion was quelled at least temporarily with an agreement Wednesday that would protect more small businesses from a requirement to provide insurance to their employees, and restructure a new public insurance plan so it could pay higher rates to doctors and other providers, among other changes. But the concessions Waxman made to the fiscally conservative Blue Dog Democrats infuriated House liberals. They denounced the proposed new structure of the government-run insurance option, which was originally designed to be based on Medicare rates. The new structure says rates would be negotiated with providers as occurs now with private companies, which could result in more expensive care. "This agreement is not a step forward toward a good health care bill, but a large step backwards," 57 Progressive Caucus members said in a letter to House leaders Thursday. "Any bill that does not provide, at a minimum, for a public option with reimbursement rates based on Medicare rates — not negotiated rates — is unacceptable." Liberals threatened to vote against the bill if it comes to the floor without a stronger public plan. Rep. Anthony Weiner, D-N.Y., an Energy and Commerce member, said they probably had enough votes to block the Blue Dog deal in committee. Some details of the deal remained murky. As part of the agreement the Blue Dogs are insisting they won't vote for a bill that costs more than $1 trillion over 10 years, but that would require Democrats to make more cuts or raise more money. It wasn't clear how much, or how it would be accomplished. As Energy and Commerce lawmakers worked through stacks of Republican and Democratic amendments, Waxman's shaky majority was on display early, when the committee voted 29-28 to defeat a Republican amendment to strengthen ID requirements designed to prevent illegal immigrants from getting Medicaid benefits. House Speaker Nancy Pelosi, D-Calif., expressed confidence the committee would approve the bill, and said the full House would follow suit in the fall. She also signaled flexibility on key issues, saying that despite her own backing for abortion rights, she would not allow the issue to torpedo legislation. Abortion has become a flash point in the health care debate, and an amendment intended to ensure any health legislation doesn't require coverage of abortions was approved 31-27 in the Energy and Commerce committee late Thursday as conservative Democrats joined Republicans to support it. Highlighting the frenetic activity the overhaul has spurred in Washington, health interests have reported spending $262 million lobbying in the first six months of 2009, more than any other portion of the economy, according to the nonpartisan Center for Responsive Politics. That was $23 million more than health-related companies and groups spent lobbying during the first half of 2008. Associated Press writers Alan Fram, Ann Sanner, Ricardo Alonso-Zaldivar and David Espo contributed to this report. Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Preparing for Vaccination
  Preparing for Vaccination with Novel H1N1 Vaccine July 31, 2009 Epidemiology In the Northern Hemisphere, novel H1N1 influenza virus is persisting, and is continuing to cause outbreaks and sporadic cases in numerous locales despite the onset of summer. Evidence to date suggests that population immunity to this virus is low, particularly among the young. Thus far, most cases of illness, hospitalization and death associated with novel H1N1 infection have occurred among persons less than 65 years of age. Groups at increased risk of influenza-related complications include pregnant women, those with asthma, COPD, diabetes, chronic cardiovascular disease, and immuno-compromised persons. These are the same groups as previously recognized to increase the risk of severe illness from seasonal influenza. In addition, morbid obesity may represent an additional risk factor for severe illness. Unlike seasonal influenza where persons 65 years and older are most likely to be hospitalized or die from influenza-related complications, this age group has been substantially less affected by novel H1N1 virus than younger age groups. Widespread susceptibility to this virus among young persons and the potential for large numbers of cases raises the possibility of more hospitalizations and deaths especially among younger age groups than would be expected for a typical routine seasonal influenza virus. The virus has also caused numerous outbreaks in schools and summer, institutions such as camps and correctional facilities, and led to disruptive interventions such as school dismissals that have substantial societal impact. Vaccine manufacturing Novel H1N1 vaccine is being procured by the U.S. government from five (5) vaccine manufacturers of currently U.S.-licensed seasonal influenza vaccines – inactivated subunit (4) and live, attenuated vaccines (1). Inactivated licensed novel H1N1 vaccine will be available in single-dose syringes, or in multi-dose vials. Live attenuated vaccine will be available in limited number in inhaler sprayers. Single-dose syringes will be thimerosal-free, which will address concerns about this additive, especially regarding pediatric and pregnant vaccine recipients (inhaler sprayer vaccine products will also be thimerosal-free). The availability of novel H1N1 vaccine is dependent on multiple factors including virus growth at commercial scale, regulatory review, availability of calibrated vaccine product potency assay reagents, overall production capacity, and availability to U.S. through HHS contracts. Vaccine purchase and allocation Novel H1N1 vaccine is being purchased by the U.S. government and will be made available for vaccinators at no cost. Syringes, needles, sharps containers and alcohol swabs will also be provided. Vaccine will be allocated across states proportional to population. State health departments (and a few separately funded cities) will direct their allocation to local health departments and other vaccination partners. Planning assumptions Given uncertainty around the amount and timing of vaccine availability, state and local public health planners have been asked to plan for vaccine becoming available mid-October under the following scenarios: 40, 80, or 160 million doses becoming available from the 5 manufacturers (total) over approximately a one month period, followed by weekly amounts of 10, 20 or 30 million doses. At this point, the planning assumption is that the vaccine will require 15 µg of antigen for an immunizing dose, and that two doses spanning over 21 or more days will be needed for efficacy for most persons. Clinical trials will be conducted to determine which age groups, if any, require only one dose. The majority of vaccine will be packaged in multidose vials but enough preloaded syringes will be manufactured for young children and pregnant women. In addition, based on best available information to date, planners have been provided scenarios to serve as a basis for making venue-based plans to vaccinate specific populations. These populations include students and staff (all ages) associated with schools (K-12th grade) and children (age ≥6 months) and staff (all ages) in child care centers; pregnant women, children 6 months – 4 years of age, new parents and household contacts of children <6 months of age, and non-elderly adults with medical conditions that increase the risk of complications of influenza, and health care workers and emergency services personnel. Formal recommendations for the use of novel H1N1 vaccine will be made by the ACIP in August 2009 based on all available epidemiologic data to date. Vaccine delivery system Many state health departments are partnering with private sector partners to ensure the novel H1N1 vaccine is delivered to as many recommended persons as rapidly as possible. Vaccine will thus be available in a combination of settings including public health organized vaccination clinics, and in private sector settings such as provider offices (e.g. pediatricians, family physicians, obstetricians, internists), retail settings, pharmacies, workplaces, and through community vaccinators. Private providers who wish to administer the novel H1N1 vaccine will need to enter into relationships with their public health department so that vaccine can be directed to them. While providers will receive the vaccine at no charge, information on reimbursement for administration is needed. CDC asked AHIP (America’s Health Insurance Plans) whether insurance plans would reimburse private providers for administration and received the following answer: “Every year health plans contribute to the seasonal flu vaccination campaign in several ways: a) Health plans communicate directly with plan sponsors and members on the current ACIP recommendations and encourage immunization; they also provide information on where to get vaccinations, and who to contact with any questions; b) Just as health plans have provided extensive coverage for the administration of seasonal flu vaccines in the past, public health planners can make the assumption that health plans will provide reimbursement for the administration of a novel (A) H1N1 vaccine to their members by private sector providers in both traditional settings e.g., doctor’s office, ambulatory clinics, health care facilities, and in non-traditional settings, where contracts with insurers have been established.” Providers participating in novel H1N1 vaccination will be expected to administer vaccine in accordance with national recommendations for use of the vaccine. In addition, if administering vaccine during the early weeks, they will be expected to report weekly on the number of doses administered and the ages of persons who were vaccinated. Such data are critical for assessing early uptake and for adverse event monitoring as they provide a means of calculating adverse events rates. Monitoring coverage, safety, and effectiveness Vaccine coverage will be monitored initially through weekly reports of doses administered, based on requirements set forth by CDC. Once the number of vaccinated persons is large enough to be detectable through population surveys, this information will be collected on an ongoing basis providing for monthly coverage estimates. The Vaccine Adverse Event Reporting System (VAERS), a national vaccine safety surveillance program co-sponsored by the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration (FDA) collects an analyzes information from reports of adverse events following immunization and will serve as the foundation for safety monitoring. VAERS accepts reports from patients, providers, public health officials and others (1-800-822-7967, http://vaers.hhs.gov/contact.htm ). Signals that are detected through VAERS will be tested using a network of managed care organizations representing approximately 3% of the U.S. population, the Vaccine Safety Datalink (VSD). Vaccination information as well as individual outcome data are available though this network both to test signals on an ongoing basis and to monitor pre-specified adverse events. Additional strategies are being developed to actively monitor Guillain Barre Syndrome (GBS) incidence during the novel HINI influenza vaccination season with networks of providers set up for active case-finding. CDC will utilize at least two primary means to assess vaccine effectiveness: the first will assess vaccine effectiveness for prevention of laboratory confirmed medically attended influenza at 4 community based sites; the second will assess vaccine effectiveness for prevention of influenza hospitalizations diagnosed by provider-ordered clinically available tests at 10 sites nationwide through the Emerging Infections Program. Additional assessments of influenza vaccine effectiveness will be conducted by the US Department of Defense which has the ability to conduct timely assessments of vaccine effectiveness in their active duty populations. Seasonal vaccination Seasonal vaccine will be available beginning in August or September 2009. The seasonal influenza vaccine is expected to be available earlier than the novel H1N1 vaccine, but the availability of the two vaccines is expected to overlap. The process for ordering seasonal vaccine is unchanged from previous years. Links to non-federal organizations are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the federal government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links. Contact Us: • Centers for Disease Control and Prevention 1600 Clifton Rd Atlanta, GA 30333 • 800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 24 Hours/Every Day • @cdc.gov Content source: Centers for Disease Control and Prevention
Most Appropriate Treatment Strategy
  Most Appropriate Treatment Strategy: Extension Of Vaccination Policy Or Prescription Of Anti-Influenza For Healthy Adults? 08 Aug 2009 The use of antiviral drugs for the treatment of people presenting with symptoms is unlikely to be the most suitable approach during a seasonal outbreak. This is the conclusion of a study published Online First and in an upcoming edition of The Lancet Infectious Diseases. The review is the work of Dr Jane Burch and Professor Lesley Stewart, Centre for Reviews and Dissemination, University of York, UK, and collaborators. It reports that the amplification of the vaccination policy could result in a more clinically efficient and cost-effective strategy. But the cost-effectiveness of this is yet to be proven. The authors mention that the findings could have significance for the current H1N1 pandemic, although the review used data for seasonal flu. They worked on a meta-analysis of the efficacy of the antiviral treatments: oseltamivir (tamiflu) and zanamivir (relenza). Healthy adults without known underlying health problems were included in the study. They also assessed individuals at risk of flu related complications, such as people with lung or heart disease, diabetes, or other health problems. In healthy adults, tamiflu reduced the median time to symptom alleviation by 0.55 days and relenza by 0.57 days. For at-risk groups, the corresponding reductions were 0.74 days (tamiflu) and 0.98 days (relenza). These reductions in symptoms are somewhat small in the perspective of the whole length of symptoms for most patients. Also, there was little information available on the occurrence of complications. Instead of treating individuals when they present influenza symptoms, some different strategies might be more clinically efficient and cost effective. These include: • Vaccination. • Post-exposure prophylaxis: treating people with antiviral drugs after they have been in contact with flu. • Expectant treatment: people that have been in contact with influenza are prescribed antiviral drugs to be taken as and when symptoms present. • Making the drugs available over the counter for purchase. • Introduction of rapid testing in the family doctor's consulting room before prescription, in order to allow the treatment only of people who have flu. Each of these options has advantages and disadvantages. However, the authors explain: "Any strategy that increases the availability of the drugs to the general public, consequently increasing the rates of inappropriate use, could increase the chances of viral strains developing resistance." They write in conclusion: "Although the evidence for clinical effectiveness in healthy and at-risk populations is similar, and the data relating to complications is lacking in both groups, it is reasonable to recommend precautionary treatment to people who are at an increased risk of suffering influenza-related complications. Even if active management of seasonal influenza in healthy adults is deemed a public health priority, recommending the use of antiviral drugs for the treatment of people presenting with symptoms is unlikely to be the most appropriate course of action, given the high specificity of zanamivir and oseltamivir to the influenza virus, and the debatable clinical importance of their affect on symptom duration. Extension of the vaccination policy might be a more appropriate choice for healthy adults, and an assessment of cost-effectiveness that includes societal costs of extending the UK vaccination policy to all working-age adults seems desirable." "Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis" Jane Burch, Mark Corbett, Christian Stock, Karl Nicholson, Alex J Elliot, Steven Duffy, Marie Westwood, Stephen Palmer, Lesley Stewart DOI: 10.1016/S1473-3099(09)70199-9 The Lancet Infectious Diseases Written by Stephanie Brunner (B.A.) Copyright: Medical News Today Not to be reproduced without permission of Medical News Today Article URL: http://www.medicalnewstoday.com/articles/160188.php New Survey Results Show Most Moms Are Aware Their Pre-teens And Teens Need Vaccines 08 Aug 2009 A new survey reports that most moms know their children need additional vaccines beyond those received when they were infants or small children. But according to Centers for Disease Control and Prevention (CDC) estimates, most pre-teens and teens do not have all the vaccinations that it recommends. As children approach adolescence they can develop risks for certain diseases and protection from some childhood vaccines can wear off over time. The survey, conducted by Harris Interactive, with support from Merck & Co., Inc., found that 4 out of 5 moms of pre-teens and teenagers agree that pre-teens and teenagers need additional vaccines beyond those they received when they were younger. However, although coverage rates for pre-teens and teens are increasing for most routine vaccines, a recent CDC report shows that most still do not have all of the recommended vaccinations. "These results mirror what I see in my own practice - a lot of adolescents not up to date on their vaccines, in spite of their parents awareness of the need for them," said Dr. Lolita McDavid, Board-Certified Pediatrician practicing at Rainbow Babies and Children's Hospital in Cleveland, Ohio. "Taking your kids - including pre-teens and teens - for an annual check-up should be as routine as buying them school supplies. About Dr. Lolita M. McDavid Lolita M. McDavid is Medical Director of Child Advocacy and Protection at Rainbow Babies and Children's Hospital, the pediatric hospital of University Hospitals Case Medical Center. She is responsible for community outreach and programming as well as coordinating the medical services for the Child Protection Unit, serving at-risk children and families in Northeast Ohio. She is an Associate Professor of Pediatrics at Case Western Reserve University (CWRU). Dr. McDavid serves on the committee of several national organizations including the Grant Review Committee and Peer Review Group at the U.S. Department of Health and Human Services and the National Advisory Committee of the Robert Wood Johnson Foundation, among others. About the Survey This survey was conducted online within the United States by Harris Interactive, with support from Merck & Co., Inc., between June 2-8, 2009 among 424 18+ female parent/legal guardian who have one or more children between the ages of 11 and 18. A full survey methodology is available upon request. About Merck & Co., Inc. Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. Source: Merck & Co., Inc Article URL: http://www.medicalnewstoday.com/articles/160173.php
Concerned about Coffee?
  Concerned about coffee? It may actually be good for you August 14, 2009 Provided by the NIH News in Health Because it tastes so good, you may assume coffee is bad for you. Maybe you've heard rumors that your morning brew causes everything from heart disease to cancer. But researchers are finding that coffee poses little to no health risk for most people. Not only that, coffee drinking might have some health benefits. Early research hinted that coffee might have some harmful effects. But most of those studies searched for links between people's habits and their overall health. In such studies, it's hard to know which effects come from coffee and which just show up by coincidence. Heavy coffee drinking sometimes goes hand in hand with unhealthy habits, like smoking and a less active lifestyle. Coffee beans are seeds and, like all seeds, they're loaded with compounds to protect the plant's next generation. "Coffee is an amazingly potent collection of biologically active compounds," says Dr. Walter C. Willett of the Harvard School of Public Health. Caffeine is probably the most well-known compound in coffee. It can make you feel more awake and alert, which is why most people drink coffee in the first place. But too much can be harmful. In fact, according to Willett, caffeine causes the most common problem reported by coffee drinkers: trouble sleeping. Caffeine can also blunt your appetite and cause headaches, dizziness, nervousness and irritability. If you're sensitive to caffeine, Willett says, simply drink less of it. If you have trouble falling asleep at night, make sure to avoid it later in the day. Caffeine is mildly addictive, so you might get headaches, drowsiness, irritability, nausea and other symptoms if you suddenly cut back. You can avoid these effects, though, by gradually reducing your caffeine intake. "There's some evidence that high amounts of caffeine during pregnancy may cause problems with the pregnancy," says Dr. Jared Reis of NIH's National Heart, Lung and Blood Institute. That's why doctors recommend that pregnant women cut back on coffee and other caffeinated beverages. Studies also suggest that caffeine may interfere with calcium absorption. Calcium is an important nutrient for growing and maintaining strong bones. Make sure you get enough calcium in your diet to help reverse this effect. Overall, says Dr. Rob M. van Dam of Brigham and Women's Hospital and Harvard Medical School, "Caffeine doesn't seem to have the wide array of detrimental health effects we first thought it had." At one time, many doctors worried that coffee might cause cancer. That's largely because caffeine damages DNA in the test tube, Willett explains, and DNA damage is linked to cancer. However, that doesn't mean that coffee causes cancer in people. Coffee also has high levels of compounds, called antioxidants, that protect DNA. "Coffee's been looked at in detail in relation to many cancers, and there's really not been any good evidence that any type of cancer is increased by coffee consumption," Willett says. "I think we can say quite confidently that there's no increased risk of cancer with coffee consumption." Some evidence even suggests that coffee may help reduce the risk of liver cancer, Willett says. NIH's National Cancer Institute is now organizing a new effort to put together data from many studies and look into this question, among many others. Some doctors thought coffee might cause heart attacks or strokes, because caffeine can raise blood pressure. But Reis says that a cup of coffee won't lead to a dramatic increase in blood pressure for regular coffee drinkers. "In long-term studies, higher levels of caffeine have not led to a higher risk of cardiovascular disease," he says. Some types of coffee can cause cardiovascular problems for another reason, however. Coffee can contain compounds that lead to a rise in LDL cholesterol. That's the "bad" kind of cholesterol that's been linked to cardiovascular disease. "A lot depends on the way in which coffee is brewed," Reis explains. "When coffee is brewed with a paper filter, it removes a lot of the components that lead to higher LDL." So it's a good idea to drink filtered coffee to avoid this problem. Coffee may even have some positive effects. Some studies have linked coffee intake with a lower risk of developing Parkinson's disease. "When looking at Parkinson's disease patients, they may be up to 4-8 times less likely to have been heavy coffee drinkers," says Dr. Wendy R. Galpern of NIH's National Institute of Neurological Disorders and Stroke. However, she points out, the studies in this area have been limited. "It's hard to know if this is just an association or if this is cause and effect," she says. Some studies suggest coffee may have other positive effects on the mind. Galpern says that researchers are now looking into the potential effects of caffeine on memory and Alzheimer's disease. Perhaps the strongest research showing a health benefit from coffee relates to type 2 diabetes. In a 2002 study, van Dam's team reported that people drinking 7 or more cups per day had a 50% lower risk of type 2 diabetes than those drinking 2 or less cups. About 20 studies have now looked into the effect in various populations. "The great majority of studies confirm that coffee is associated with a lower risk for type 2 diabetes," van Dam says. Researchers aren't sure why coffee has this effect, but some compound other than caffeine is responsible. "We did a study of decaffeinated coffee and essentially found the same association as caffeinated coffee," van Dam says. Another potential benefit from coffee is that it can keep you from drinking less healthy things. "We think that coffee is actually quite a good beverage compared to other beverages," van Dam says. "It can be a reasonable beverage choice if you don't add a lot of cream and sugar." Coffee can also help your social life, if you meet good friends to talk over coffee. Studies have clearly shown that people who have more social relationships have less stress and live longer. Research also suggests they're less likely to show mental declines as they age. So go enjoy that cup of coffee. It's not the guilty pleasure you may have thought. Get Smart About Swine Flu For Back-To-School By Amanda Gardner, HealthDay Reporter FRIDAY, Aug. 14 (HealthDay News) -- Students returning to school this year have another worry besides homework and lunchroom bullies: swine flu. Experts say parents and kids need to act early and vigorously to reduce their risk of contracting the H1N1 virus. "We do know that [the virus] is going to strike the school-age child and it's primarily because they're in crowded classrooms with lots of other children and have a better chance of spreading germs," said Sharon A. Wilkerson, dean and professor of the Texas A and amp;M Health Science Center College of Nursing in College Station. "Parents need to pay attention earlier and more urgently. We're still seeing cases of swine flu and I think we're going to see an increase with the start of the school year." "We're giving advice with a new conviction," added Dr. Michael Spigarelli, assistant professor of pediatrics and internal medicine at Cincinnati Children's Hospital Medical Center. "The common perception is that kids are going to get sick and a certain amount of getting sick is how the immune system builds itself up. We're saying that this flu season may be potentially worse." According to the U.S. Centers for Disease Control and Prevention, more than 55 million students and 7 million staffers head to the nation's 130,000 schools each weekday during the school year. As always, the first line of protection will be good hygiene. "The main thing is good hand-washing," said Dr. Stuart E. Beeber, an attending pediatrician with Northern Westchester Hospital Center in Mount Kisco, N.Y. If soap and water aren't readily available, make sure your child has hand sanitizers in their backpack, along with other school supplies. Washing or sanitizing should take place before every meal and every snack, even if it's just cookies in the classroom. "We've just got to drill that into children," Wilkerson said. Finally, "if you cough, cough into your arm or use tissues," Beeber stressed. Children who are sick should be kept home, especially if they're running flu-like symptoms such as high fever, vomiting or diarrhea, Wilkerson said. They should also be kept away from other children. In back-to-school recommendations issued Aug. 7, the CDC advised that schools set aside a room for people developing flu-like symptoms while they wait to go home and that surgical masks be used for ill students or staff and those caring for them. Any child who has been sick should be fever-free for at least 24 hours (without the aid of medications) before returning to school, Beeber added. Definitely seek medical care if a child becomes sick, but don't take children with flu-like symptoms to the emergency department, Wilkerson urged. "That's the worst thing. They may not have swine flu but they could get it [there]," she said. Instead of rushing to the emergency department, "people need to call their physicians or call a hotline," Wilkerson said. Widespread school closures that swept across the United States last spring needn't be repeated this fall, the CDC has said. "I don't think that we're going to see that panicky reaction," according to Wilkerson. But the CDC guidelines noted that everything could change if the outbreak suddenly turns severe. In those cases, the agency said, some schools may need to be closed, and certain precautions -- for example, spacing school desks farther apart -- might need to be imposed. Immunization could also be of great help, the experts noted. Children should be vaccinated for the regular, seasonal flu as soon as a vaccine is available, which hopefully will be earlier than the usual October-November time frame. Trials involving about 2,800 people are also underway for an H1N1 flu vaccine, with officials hoping to have 160 million doses available starting in mid-October. "The vaccine will most likely, at least for children, require two doses separated by about three weeks or more," CDC director Dr. Thomas R. Frieden told reporters last Friday. The antiviral drugs Tamiflu and Relenza are also available to help people who come down with influenza but, according to a recent study in the BMJ, they may not prevent complications in children with seasonal flu. This raises the question of whether they would help protect kids from the swine flu, either. The good news is that the swine flu does not seem to be worsening in severity, even as it winds its way through the Southern Hemisphere. "We haven't seen the evidence that it's the most lethal thing we've seen since 1918 [the Spanish flu pandemic]," said Spigarelli. "We haven't seen it get terribly bad in the Southern Hemisphere. We're not seeing elementary schools being wiped out because of the swine flu." More information There's more on the H1N1 flu at the U.S. Centers for Disease Control and Prevention. SOURCES: Stuart E. Beeber, M.D., attending pediatrician, Northern Westchester Hospital, Mt. Kisco, N.Y.; Sharon A. Wilkerson, Ph.D., R.N., dean and professor, Texas A&M Health Science Center College of Nursing, College Station, Texas; Michael Spigarelli, M.D., Ph.D., assistant professor, pediatrics and internal medicine, Cincinnati Children's Hospital Medical Center; Aug. 7, 2009, news telebriefing, with Thomas R. Frieden, M.D., director, U.S. Centers for Disease Control and Prevention Copyright © 2009 ScoutNews, LLC. All rights reserved.
'Explosion' of Swine Flu Cases Predicted
  'Explosion' of Swine Flu Cases Predicted By GILLIAN WONG August 21, 2009 BEIJING (Aug. 21) — The global spread of swine flu will endanger more lives as it speeds up in the coming months and governments must boost preparations for a swift response to a coming "explosion" of cases, the World Health Organization said Friday. Many countries could see swine flu cases double every three to four days for several months until peak transmission is reached, once cold weather returns to the northern hemisphere, said WHO's Western Pacific director, Shin Young-soo. "At a certain point, there will seem to be an explosion in case numbers," Shin told a symposium of health officials and experts in Beijing. "It is certain there will be more cases and more deaths." The WHO says the swine flu virus — also known as H1N1 — has killed almost 1,800 people worldwide, and has declared a pandemic. International attention has focused on how the pandemic is progressing in southern hemisphere countries such as Australia where winter — and the flu season — has started. But it is in developing countries that the accelerated spread of swine flu poses the greatest threat as it places underequipped and underfunded health systems under severe strain, Shin said. WHO earlier estimated that as many as 2 billion people could become infected over the next two years — nearly one-third of the world's population. Others said Shin's cautionary comments were needed but that they were optimistic the spread would not be that serious. Ann Moen, an influenza expert with the U.S. Centers for Disease Control and Prevention, said that if current trends continue it is possible that the swine flu pandemic will not be worse than a severe flu season. "I think the world was preparing for an H5N1 (bird flu) pandemic and we didn't get that. So maybe this is our supreme tabletop exercise, a global sort of practice for something bigger," Moen told The Associated Press. Health officials and drug makers are considering how to speed up production of a vaccine before the northern hemisphere enters its flu season in coming months. Estimates for when a vaccine will be available range from September to December. Delegates from Bangladesh and Myanmar appealed for help in procuring vaccines or making them more affordable for poorer countries, saying they were left vulnerable while rich nations pre-ordered most of the available stock. "Developing countries like us, we have to fight this war without vaccines," said Mya Oo, deputy health minister of Myanmar. He urged pharmaceutical companies to consider selling the vaccines to developing countries at just above cost. WHO's flu chief, Keiji Fukuda, said the agency was working hard on the issue, and noted that two drugmakers had pledged to donate 150 million doses of vaccine to poorer countries by the end of October. He said more research was needed to determine how vaccines will be priced. "Among the many pandemic response issues, this is probably the most critical issue: how we mobilize the vaccines, how we get them to developing countries," Fukuda said. WHO has stressed that most cases of swine flu are mild and require no treatment, but the fear is that a rash of new infections could overwhelm hospitals and health authorities, especially in poorer countries. Shin said governments must quickly educate the public, prepare their health systems to care for severe cases and protect those deemed more vulnerable to prevent unnecessary deaths. "We only have a short time period to reach the state of preparedness deemed necessary," Shin said. "Communities must be aware before a pandemic strikes as to what they can do to reduce the spread of the virus, and how to obtain early treatment of severe cases." Pregnant women face a higher risk of complications, and the virus also has more severe effects on people with underlying medical conditions such as asthma, cardiovascular disease, diabetes, autoimmune disorders and diabetes, WHO chief Margaret Chan said in a video address. The last pandemic — the Hong Kong flu of 1968 — killed about 1 million people. Ordinary flu kills about 250,000 to 500,000 people each year. Swine flu is also continuing to spread during summer in the northern hemisphere. Normally, flu viruses disappear with warm weather, but swine flu is proving to be resilient. Copyright 2009 The Associated Press. The information contained in the AP news report may not be published, broadcast, rewritten or otherwise distributed without the prior written authority of
Surgical Scrun Solution
  Surgical Scrub Solution: It's Good For Patients, Too 05 Sep 2009 Giving critically ill hospital patients a daily bath with a mild, soapy solution of the same antibacterial agent used by surgeons to "scrub in" before an operation can dramatically cut down, by as much as 73 percent, the number of patients who develop potentially deadly bloodstream infections, according to a new study by patient safety experts at The Johns Hopkins Hospital and five other institutions. Bloodstream infections, they say, strike as many as one in five patients in hospital intensive care units and up their chances of dying by as much 25 percent. Even when they are not fatal, such infections have been reported to lengthen hospital stays by an average of a full week and add as much as $40,000 in costs. The new study, described this summer in the June issue of the journal Critical Care Medicine, tracked daily neck-to-toe sponge baths with a mild, 4 percent solution of chlorhexidine glutonate, given to 2,650 ICU patients at six different U.S. hospitals. Chlorhexidine glutonate is the same antibacterial agent used by surgeons while scrubbing in for an operation and by dentists as a potent mouthwash to guard against gum disease. Weekly swab testing found 32 percent fewer patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) and 50 percent fewer cases of vancomycin-resistant Enterococci (VRE), when compared to a similar number of ICU patients (2,670) at the same hospitals who were washed with just plain soap and water. MRSA and VRE are the two most common so-called hospital superbugs. "Doing everything possible to ward of bloodstream infections and halt the spread of these dangerous bacteria is essential to safeguarding our patients' well-being, encouraging their speedy recovery and sparing valuable hospital resources," says study co-investigator Trish Perl, M.D., director of hospital epidemiology and infection control at Johns Hopkins. "It's just as important to find the right soap to prevent infection as it is to find the right drug to treat patients who develop an infection," says Perl, a professor of medicine and pathology at the Johns Hopkins University School of Medicine. "Our results show that using chlorhexidine [glutonate] as a daily washing agent is a simple, effective and relatively cheap way to protect the health of our most vulnerable patients," she adds, noting that various products cost very little. A 320-ounce bottle of the scrub solution costs as little as $6 a bottle, while 15 milliliter packets cost 33 cents each. It is also available as either a solid reddish-colored bar or an even milder baby-wipe type cloth containing a 2 percent chlorhexidine glutonate solution (at a cost of $2.57 for a pack of two.) Perl says the goal is to "actively remove" bacteria that may be harmful to the patient or other patients in the hospital, people at greater risk of infection because of a weakened immune system or from use of medical devices that may offer a route for bacteria to enter the body. "Because these bacteria have built up resistance to many of the most common antibiotic drugs used to kill them, our goal is to stop them from infecting patients or from spreading from patient to patient, as we are left with few options for treatment after they colonize and then infect a patient," says Perl, who points out that the chemical's antibacterial effects can last from six to 48 hours, depending on the strength of the solution. "And altering the daily bathing routine is a simple and effective means of doing so because it involves no additional workload for nurses," she says. The study showed no skin rashes or adverse events during the test period, between December 2004 and January 2006. Each critically ill patient was tested for infectious bacteria within 48 hours of admission and then weekly thereafter with either nasal or buttock swabs, and for the remainder of their hospital stay. Among some 500 patients whose stay in hospital was long (at least 10 days), 11 who were washed with chlorhexidine had MRSA and five developed bloodstream infections. By contrast, MRSA was detected in 27 of a similar group who were bathed with plain soap, with eight developing bloodstream infections. Similarly, with VRE, nine patients in the chlorhexidine group had bloodstream infections, while 33 were infected in the plain-soap group. As part of routine hospital procedures, any patients found to be infected or to be a carrier before infection has set in are placed in isolation for the remainder of their stay. Wound care is done only in designated, confined treatment spaces or separate rooms, and hospital staff must take special precautions between treatments, such as cleaning equipment and furniture with strong disinfectants and wearing disposable gloves, masks and gowns. Perl says chlorhexidine has been in use since the 1950s, but its practical value had "not been appreciated" until now, citing the chemical's occasional use as a treatment for recurrent pimples as the main reason why the multicenter research team conducted the latest study. "Our research is particularly important for preventing MRSA and other drug-resistant infections in children," she adds. Her team's previous research in 2007 showed that children admitted to Hopkins are increasingly identified as harboring MRSA or VRE, with four times as many children admitted to the pediatric ICU with MRSA and twice as many with VRE than five years ago. In 2006, the Joint Commission estimated that 70 percent of the bacteria that cause infections for 2 million hospitalized Americans each year are resistant to at least one of the drugs most commonly used to treat them. Perl's only caution is the need for long-term monitoring to make sure that hampering the growth of one kind of bacteria -- both S. aureus and Enterococci or so-called gram-positive bacteria -- does not promote the growth of other kinds, specifically, gram-negative bacteria. Funding for the study was provided by the U.S. Centers for Disease Control and Prevention (CDC). Besides Perl, another Hopkins researcher involved in this survey was Kathleen Speck. Investigators elsewhere included lead investigator Michael Climo, M.D., Jaime Robles, Ph.D., and Edward Wong, M.D., all at the Commonwealth University Medical Center, in Richmond, Va., with Climo and Wong also based at the Hunter Holmes McGuire Veteran Affairs Medical Center, also in Richmond; Kent Sepkowitz, M.D., and Gianna Zuccotti, M.P.H., at Memorial Sloan-Kettering Cancer Center in New York; Victoria Fraser, M.D., and David Warren, M.D., at Washington University School of Medicine in St. Louis, Mo.; and John Jernigan, M.D., at the CDC. Source: Johns Hopkins Medicine Article URL: http://www.medicalnewstoday.com/articles/163082.php Day Care Centers Urged To Be Vigilant Against Flu By LAURAN NEERGAARD, AP Medical Writer Lauran Neergaard, Ap Medical Writer Fri Sep 4, 2009 WASHINGTON – Will you start seeing thermometers at day care centers? The government is urging the nation's 360,000 child care providers to be vigilant about sending home children who may have the flu — and the main symptom to check for is a fever. The Centers for Disease Control and Prevention issued guidelines Friday for day care programs that echo the advice for schools: Kids need vaccine — against both regular flu and the new swine flu — and they should stay home when they're sick. Don't return until 24 hours after a fever naturally subsides. "If your child comes down with the flu, we hope you plan to keep them home and not share this with their playmates," Health and Human Services Secretary Kathleen Sebelius said. The guidelines urge day care providers to do a quick health check every day, looking for children with flu-like symptoms or other signs that they might be getting ill, such as not playing normally. Centers should separate the sick child from others until he or she can be taken home. But it can be very hard to tell if a child is sneezing because of flu, the common cold or even allergies. "There are many, many different kinds of respiratory illnesses that children get, and we don't want to be sending children home unnecessarily," said Dr. Beth Bell, a CDC epidemiologist. So checking for a fever is what Bell called a "reasonable indicator" of flu, either the regular winter strains or the swine flu that scientists call the 2009 H1N1 flu. While not everyone with swine flu has a fever, the CDC has said such cases are rare. Regular winter flu kills 80 to 100 U.S. youngsters every year, so children are supposed to get vaccinated against it each fall. But swine flu is putting new emphasis on flu and kids: At least 40 children have died of it since spring, accounting for about one in 13 U.S. swine flu deaths, the CDC said this week — and it spreads very easily among children. One puzzle: While regular winter flu is most dangerous to children 4 and under, most children who have died of swine flu so far are age 5 to 17. It's possible that that's because school-age children are the group most infected so far, but scientists aren't sure. Regardless, children of all ages are supposed to be among the first in line to get swine flu vaccine when it arrives in mid-October. Vaccine against both types is a good idea for day care workers, too, Sebelius said. It could mean the difference between a center staying open or having to close because of absent staff. Any child care workers that care for infants, or who themselves have high-risk conditions, will be among priority groups for swine flu vaccine. "It's the best way to keep them safe and the way to keep the children in the center safe," Sebelius said. Meanwhile, day care centers also should stress commonsense flu-fighters: Wash hands often, and teach children to cough and sneeze into their elbow, not the hand they'll immediately stick onto a toy or a neighbor. A key way that flu spreads is for someone to touch a germy surface and then touch their nose mouth.
Healthcare Reform in Plain English
  Finally, Healthcare Reform In Plain English Russell Turk, M.D. Sep 12th 2009 Nine months after taking office, President Obama outlined his plan for overhauling the nation's health care system in a speech before Congress on Wednesday. It was long overdue. Sixty-seven percent of respondents to a CBS News poll released last week said they didn't have a clear understanding of health care reform ideas because they found them too confusing. One of the reasons Americans are so puzzled is that President Obama hasn't done a good job explaining why we need reform or how his strategy will help fix the problem. His message got lost in translation. Meanwhile, opponents have spelled out succinctly and effectively the failings of the Democrats' proposed plan -- and they've thrown in a few fabrications to boot. By using misleading words and phrases like "rationing," "government takeover" and "socialized medicine," and some truly ludicrous ones like "death panels" and "killing grandma," opponents of the president's plan have convinced many Americans that the health care reforms under consideration are indefensible. As New York Times columnist Charles Blow put it, "Conservatives speak in bumper stickers. Obama speaks in thesis statements." That changed on Wednesday night when the president finally addressed critics head on, countering fallacies with facts. He spoke clearly, plainly and with authority about what's wrong with our nation's health care system and what needs to be done to fix it, and he defined the broad goals of his plan. "It will provide more security to those who have health insurance," he said. "It will provide insurance to those who don't, and it will slow the growth of health care costs for our families, our businesses and our government." Some of this is quite complicated, and the president put it in the simplest terms possible. He probably didn't change many Republican congressmen's minds, but he may have gotten the attention of some citizens on the fence and those who were not sure what to think, in part by acknowledging valid ideas put forth by Republican lawmakers. As a physician, I am particularly encouraged by the possibility that medical malpractice reform might be included in the legislation, since this has been sorely missing from the debate. At the same time, the president stuck to his core message that we need to provide quality health care to all Americans. He said that one in three Americans have gone without health insurance at some time in the past two years. That seems about right based on anecdotal evidence in my practice. But the president pointed out that reforms are also necessary for the people with insurance. "Those who do have insurance have never had less security than they do today," he said. It's now incredibly common to see patients who have either lost their jobs or are about to -- and they risk losing their health insurance as well. All President Obama or any politician needs to do is spend one week in my office or that of any doctor in America to see first hand how inefficient and unfair the health insurance industry is, and how frustrated both doctors and patients are as a result. I saw a patient this week who was about to pay $1,500 out of pocket for a battery of lab tests (a Pap test, HPV test, STD screening and a cholesterol test) because her insurance company denied coverage. The first few tests are routine screenings for cervical cancer and the cholesterol test is obviously a preventive screening tool. The patient said she couldn't afford to have a colposcopy, a diagnostic test for cervical cancer even though the procedure was clearly necessary in her case. Fortunately, after the patient and my office staff spent two hours on the phone, the insurance company reprocessed the first panel of tests and covered them. Let me point out that the patient was a bright, educated woman; those without her persistence might not know to push back and challenge a denial of care. I witness manipulative tactics like this by insurance companies every day that make it difficult for patients to navigate the system and get the quality care they're entitled to. The question is: Have enough Americans had similar experiences that the president's speech will serve as a wake up call to take action? Maybe Obama's simple yet stirring speech will inspire people to support the efforts to fix this problem, rather than let politics derail it. Did he leave out details? Yes, there are still a lot of specifics to be worked out, which is why laughter erupted in the chamber when President Obama said, "There remain some significant details to be ironed out." But that's where Congress steps in to consider the various options and ideas, and to find compromise in order to close the deal. So much of what has and will be written about the president's speech is partisan: The focus is on whether Obama will regain popularity in the polls and reinvigorate a faltering presidency or if Republicans will succeed in killing health care reform once again. From my perspective, this is not a chance to win a political victory. This is about finally being within reach of a health care system that works -- for everyone. Russell Turk, M.D., is an obstetrician and gynecologist in Fairfield County, Connecticut. Patients With Medical Homes Receive Better Primary Care At No More Cost 02 Sep 2009 A one-year evaluation at Group Health Cooperative is the first to demonstrate the measurable benefit to both patients and staff when a primary care practice adopts a "patient-centered medical home" model. This model gives patients more time with doctors, more preventive care, and improved collaboration among caregivers. The September 2009 American Journal of Managed Care will publish the results - which include significantly fewer emergency room visits and hospitalizations. Much national attention is focused on the medical home model as a way to improve health outcomes, control costs, and help solve the U.S. shortage of primary care (from generalists). A medical home provides expanded primary care that is personalized, focuses on prevention, actively involves patients in making decisions about their care, and helps coordinate all their care and get their health needs met. The new study provides some of the nation's first empirical evidence of the benefits of this new type of care. It compared a random sample of the 9,200 patients at Group Health's medical home to a control group. At one year, patients at the medical home: • Had 29 percent fewer emergency room visits, 11 percent fewer hospitalizations that primary care can prevent, and 6 percent fewer in-person visits • Reported higher ratings on six scales of patient experience • Used 94 percent more e-mail, 12 percent more phone, and more group visits and self-management support workshops Received better health care, including needed screening tests, management of their chronic illnesses, and monitoring of their medications "A medical home is like an old-style family doctor's office, but with a whole team of professionals," explained evaluation leader Robert J. Reid, MD, PhD, an associate investigator at Group Health Center for Health Studies and Group Health's associate medical director for preventive care. "Together, they make the most of modern knowledge and technology - including e-mail and electronic medical records - to give patients excellent care and reach out to help them stay healthy." Now 25 medical home projects are active in 17 states. Still, to date, much enthusiasm for the medical home has been based on qualitative observation. This evaluation provides more quantitative evidence. Only 10 percent of the medical home doctors, nurses, and staff felt "burned out" or emotionally exhausted, vs. 30 percent of controls. Reducing burnout is key to improving health care. "Many primary care providers work so hard, they feel like they're on a hamster wheel," Dr. Reid said. They often also earn much less than specialists, particularly outside such systems as Group Health, which pay doctors a salary to care for a group of patients, not "fee for service" (more money for more tests and treatments). The shortage of U.S. primary care providers is a crisis, he added. Most U.S. medical students choose to specialize, and primary care physicians retire earlier than specialists do. Group Health put much thought - and resources - into improving primary care in the medical home pilot. Each primary care doctor (family physician or general internist) was responsible for fewer patients: 1,800 instead of 2,300. That left time for outreach, coordination, daily "team huddles," and longer office visits: 30 vs. 20 minutes. But it also meant investing $16 more per patient over the year in extra staffing: for 72 percent more clinical pharmacists, 44 percent more physician assistants, 18 percent more medical assistants, 17 percent more registered nurses, and 15 percent more primary doctors. On average, patients at the medical home used $37 more specialty care, perhaps because the enhanced primary care detected previously hidden health problems. "Our evaluation showed these costs were recouped within the year," Dr. Reid said. The main reason was emergency room savings of $54 per patient in the course of the year. "These findings are important because they provide a 'proof-of-concept' that investments in a medical home can achieve relatively rapid returns across a range of key outcomes." Impressed by the return on investment, Group Health is expanding the medical home model from its Factoria medical center in Bellevue, WA, to all 26 of its medical centers. "Patients fortunate enough to have health care centered on their needs and delivered by Group Health have already seen the future," said Paul Grundy, MD, MPH, president of the Patient Centered Primary Care Collaborative. "This work is a new model that can help address our nation's need for better access to primary care." Group Health Cooperative funded the medical home pilot and evaluation. Dr. Reid's co-authors are Paul Fishman, PhD; Onchee Yu, MS; Tyler R. Ross, MA; James T. Tufano, MHA, PhD; Michael P. Soman, MD, MPH; and Eric B. Larson, MD, MPH. Source: Rebecca Hughes Group Health Cooperative Center for Health Studies
Nasal Spary Flu Vaccine
  Nasal Spray Flu Vaccine Becoming Available By LAURAN NEERGAARD October 3, 2009 AP WASHINGTON -The long-awaited first vaccinations against swine flu — the squirt-in-the-nose kind — begin early next week in parts of the country, and states are urging people to be patient until more arrives. Just a trickle of vaccine, 600,000 doses of the nasal spray FluMist, will be divided among 21 states and four large cities by Tuesday, with more small shipments to more states later in the week. "We're moving this out as quickly as we can," said Oregon's public health director, Dr. Mel Kohn, who hopes shipments arrive in time to begin some vaccinations on Monday. "This doesn't do any good sitting in a warehouse." Most states are aiming their first small batches at health care workers, hoping to keep them well enough to be on the job as cases of swine flu — what doctors prefer to call the 2009 H1N1 strain — are rapidly increasing nationwide. In Chicago, firefighters will share first doses with hospitals, to get some emergency responders protected, too. Alaska wants its meager first 4,000 FluMist doses to head directly to preschoolers, ages 2 to 4. And Pennsylvania will target its initial 58,000 FluMist doses mostly to 5- to 9-year-olds in parts of the state where H1N1 is most active. It's the school-age kids who are getting infected most, said Pennsylvania's acting physician general, Dr. Stephen Ostroff, and the under-10 crowd is going to need two doses of swine flu vaccine. "Our figuring is, let's get started in the group that's going to take longest to get protected," he said. Stay tuned: How much vaccine is available and for whom is going to change week by week. "This is really just the beginning," said Dr. Anne Schuchat of the U.S. Centers for Disease Control and Prevention. "We need a little bit of patience the first couple of weeks." Indeed, some states were surprised that the first shipments were FluMist, which is only for healthy people ages 2 to 49, which leaves out some of the groups at high risk for H1N1 flu. The more common flu shot will be close behind, part of the 6 million to 7 million doses of vaccine the CDC expects to ship around the country by the end of next week. Far larger batches — about 40 million doses — start shipping the second week of October. That's when states expect enough of both shots and FluMist to start heavily targeting the high-risk groups: pregnant women, children and young adults from 6 months to 24 years, the young and middle-aged who have flu-risky conditions like asthma or diabetes, and caregivers of infants. Hospitals in Pinellas County, Fla., plan to give new parents a special reminder. On the newborn checklist — infant car seat, going-home outfit — comes a plea to get themselves vaccinated before discharge. Because newborns can't be vaccinated, "the only way to protect your baby is for Mom, Dad and the family to receive the vaccine," the flyer says. By the end of October, Arizona expects 1 million doses on hand, enough for schools to start onsite vaccination programs, said Health Services Director Will Humble. What about everybody else? Massachusetts officials are warning that people who aren't at high risk from swine flu may have to wait until November for an H1N1 shot. In other states, officials are more optimistic. Milwaukee has earmarked its first shipment for health workers and its second for schoolchildren, kindergarten through high school. Then by late October, "we should be able to open it up to anyone who wants it," said Milwaukee's disease-control chief, Paul Biedrzycki. "We're expecting two to three times the demand for seasonal flu vaccines." This year brings an unusually complex vaccination schedule: Most people will need two different inoculations, one against regular winter flu and the H1N1 vaccine. Plus, children under 10 will need two H1N1 doses. The federal government bought the nation's entire supply of H1N1 vaccine and is dividing doses as they arrive among states according to population. State health departments submit orders, and doses are shipped to the vaccination sites the states deemed able to quickly get shots into arms and squirts up noses — a mix of doctors' offices, hospitals, drugstores and public clinics. CDC in turn will track those shipments to see how fast vaccine is used, and for whom, to ensure the populations at highest risk are vaccinated. Associated Press writers Carla Johnson in Chicago, Marc Levy in Harrisburg, Pa., Christine Armario in Tampa, Fla., Bob Christie in Phoenix, Dinesh Ramde in Milwaukee, Tim Fought in Portland, Ore., Dan Joling in Anchorage, Alaska, and Steve LeBlanc in Boston contributed to this report. Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. 2009-10-02 20:27:02
Scary Vacinnation Situation
  10/16/2009 It's a scary vaccination situation By: Jeffery Kurz Every year, the flu season and the task of vaccinating the most vulnerable can get complicated, but for a lot of health care workers, nothing compares to this year. "We've had difficult years, but this is obviously the worst," Mary Lenzini told me. She should know. Lenzini is president of the Visiting Nurse Association of Southeastern Connecticut, which covers along the shoreline and in, from Old Saybrook to Rhode Island. Lenzini's organization ordered 5,000 doses of the seasonal flu vaccine, but received just 810, and as a result has canceled all of the flu clinics planned for this season. That leaves a lot of people, many of them the senior citizens who need it the most, in a position of having to scramble to find the vaccine. Visiting nurse associations, or VNAs, as they're typically called, have traditionally been the source of seasonal flu vaccines, in many cases because they have a long tradition of serving the elderly. Providing flu vaccines is also a way of bolstering finances. According to the Department of Health and Human Services, in an average year 226,000 Americans are hospitalized because of seasonal influenza and about 36,000 die from it. Most of those who die from it are el-derly. So, as if it needs to be said, the shortage of the seasonal flu vaccine, or even a delay in its availability, is for many a serious issue. What's complicating the situation this year is preparation for the H1N1 influenza virus. The nation's manufac-turers were under pressure to provide millions of doses of the vaccine for H1N1, also called the swine flu. In part because of that pressure, the distribution of the seasonal flu vaccine has been cut back, or delayed, in many parts of the country, including Connecticut. There's no getting around the impression that H1N1 is scary, and the public attention being drawn to this new strain of flu, and much media hype, has likely led to more interest in getting a vaccine for the seasonal flu, as well. Despite the attention, or maybe even because of it, there remains confusion about the flu situation this year, and part of that is because the swine flu is a moving target. Nobody can really tell how severe it will get. There are a couple of reasons why the H1N1 virus is at least a little scary. One is that it is pandemic, which simply means that it has spread to many countries. Another is that it is a new strain of virus, which makes it much different from seasonal flu viruses. Seasonal vi-ruses are related, so if you've had the flu in the past, your body has built up some immunity. Bodies have no such preparation when it comes to H1N1. There are two types of vaccines targeted for the 2009 H1N1 influenza; neither will do any good when it comes to preventing seasonal flu viruses. The nasal spray vaccine, the one mostly available at the moment, is also referred to as live, attenuated, which means it is weakened to not cause illness. The nasal spray is licensed for people from 2 to through 49 years old. The H1N1 flu shot is inactivated vaccines, which means it contains killed virus. The flu shot has preservatives, including thimerosal, which some have suspected of being linked to autism, though studies and reviews of studies have shown that's not the case. Because the seasonal flu season can last from November to May, it's probably a good idea to get the seasonal flu vaccine even if it's as late as December, or even later. Let's hope that in the effort to combat a scary new virus, the situation with the one we're familiar with hasn't been made worse. ©www.MyRecordJournal.com 2009
12 Bright Reasons
  12 Bright Reasons To Guzzle Down Pomegranate Juice Submitted by Ricky on November 13, 2009 Pomegranate juice has been touted by health experts for its myriad of health benefits. A single glass of pomegranate juice constitutes nearly forty percent of the US RDA or recommended daily allowance of Vitamin C. It additionally has an influx of Vitamin A, E and folic acid. Pomegranate juice is rich in antioxidants, even surpassing the antioxidant content present in purple grape juice, cranberry, blueberry, orange, red wine or green or black tea by three folds. Numerous studies have revealed the major benefits to health from consuming pomegranate juice. Below stated are the twelve ways in which it is a boon to our health. Reduces Incidence of Breast Cancer and Skin Cancer Research carried out in Israel reveal that pomegranate juice aids in obliterating breast cancer cells, while sparing healthy tissues. It could additionally prevent the malignant cells from developing. Inhibitor of Lung Cancer Studies conducted on mice have proved pomegranate juice could hinder lung cancer development. Dawdles the spread of Prostate Cancer It has been proven in mice to slacken the spread of prostate cancer and lower the risks of prostate cancer. ‘As good as’ Viagra Pomegranate juice is the solution for those men that desire to bolster their act in bed. A glass of pomegranate juice is has been vouched to have analogous effects to that of a dose of Viagra. Studies suggest that its antioxidant rich nature raises the circulation of blood to the genital region. Almost half populace of men in the study felt that drinking pomegranate juice help them easily perform. Stabiliser of PSA Levels During a research conducted on fifty men having prostate cancer that underwent treatment, it was found that daily intake of eight ounces of pomegranate juice had a stabilising effect on the PSA levels, thus lowering the requirement for additional treatments like chemotherapy or hormone therapy. Safeguards Neonatal Brain functioning Research revealed that those expectant mothers who consumed pomegranate juice might be offering protection to the neonatal brain from harm subsequent to injury. Helps prevent Osteoarthritis Numerous studies reveal that cartilage deterioration could be averted by the regular intake of pomegranate juice. Pomegranate juice has a tendency to have an inhibiting action on the enzymes that cause cartilage damage. Combats atherosclerosis It helps to fight against the build up of plaque in the arteries that occurs due to atherosclerosis leading to lowered flow of blood raising chances of strokes and heart attacks. The juice could even annul earlier plaque that had developed. The studies reveal that pomegranate juice lowered the effects of stress and strain on blood vessel cells in the human body by eliciting the manufacture of nitric oxide which is the chemical believed to aid in maintaining optimal blood flow and keeping the arteries open. Postpones the onset of Alzheimer’s Disease A study conducted where in mice were reared to develop Alzheimer’s disease were offered pomegranate juice. These rats had perceivably lower accumulation of amyloid plaque and also exhibited better cognitive performance as compared to the control mice. Lowering Bad Cholesterol levels It is known to deplete the levels of bad cholesterol (LDL) and raise good cholesterol levels (HDL). It has also been shown to have blood thinning properties. Reduces Blood Pressure Levels A study revealed that daily consumption of 1.7 ounces of pomegranate juice helped in lowering the systolic blood pressure by nearly five percent. Prevents Dental Plaque Studies reveal that drinking pomegranate juice might be an innate means to averting dental plaque. Disability Plan Could Be Another Roadblock To Health Reform Bill 12 Nov 2009 The Washington Times reports that an "insurance plan championed by Sen. Edward M. Kennedy that would help elderly or disabled people avoid nursing homes ironically adds yet another sticking point to the comprehensive health care reform plans" in Congress. Moderate Democrats and Republicans worry the Community Living Services and Support Act will increase the deficit and make the federal government responsible for another insurance program. "Under the proposal in the House-passed version of the overhaul, the CLASS Act fund would collect monthly premiums, estimated to be $65 in 2011, from the wages of all working Americans, unless they elect to opt out - a technique used to help drive participation. Once they pay premiums for five years, participants would be eligible for cash benefits to help them buy in-home care, if they can no longer care for themselves." Several senators have expressed concerns that purported savings on the plan don't start until 2016 and that benefits paid will outweigh premiums gathered (Haberkorn, 11/11). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved. November 2009 No Quick Fix In the National Debate over Health Reform, Massachusetts Is Ahead of the Game BY JOSEPH BEDNAR As debate rages in Washington over the size, scope, and details of national health care reform, no one can say with any certainty what shape a final bill will take. Supporters of government intervention in health care say the U.S. has an obligation to ensure that its people have access to basic medical services, while opponents point to the massive cost of a proposed new entitlement at a time of already-soaring federal debt. But here in the Bay State, the recent law mandating health insurance for most residents and progress toward significant changes in the way hospitals and doctors are paid position the state on the cutting edge of the debate — and those developments, some predict, will make the transition to national health reform easier for Massachusetts than for other states. “That’s what we’re hoping,” said Daniel Keenan, senior vice president of Government Relations at Mercy Medical Center. “From a policy perspective, it feels like we have resolved the access issue, and there’s a lot of discussion at the federal level about how to do what Massachusetts has already done.” The Commonwealth has done more than mandate insurance coverage. It has started to shine a light on the cost and quality of care at hospitals, making the information publicly available and encouraging hospitals to reduce complications and costly readmissions, while also considering drastic changes in the way providers are paid to reduce bloat and waste. “Massachusetts as a whole is far ahead of the rest of the nation when it comes to health care reform,” Keenan said. “Most of what’s being contemplated at the federal level is taking place here. We have 97% insured in the state, and the federal proposals, even in the most progressive model, won’t get that high. The only thing we’re not fully progressed on is the cost measures.” And cost, of course, is the major concern of most opponents of reform on the national level, or at least those who are skeptical of an expanded government role in health care. Dollars and Sense The two bills currently being promoted by Democrats in the U.S. House and Senate (Republican support is virtually nil) both propose a ‘public option’ in competition with private insurers, although the Senate bill would allow states to opt out if they wish. Hoping to get a bill passed by year’s end, lawmakers continue to debate issues like how rates to pay doctors, hospitals, and other providers will be set; what penalties to assess employers who do not provide insurance and individuals who choose not to purchase it; and how reform will be paid for, likely a combination of taxes and Medicare cuts. Proponents of both bills put their cost at or just under $900 billion over 10 years, and the Congressional Budget Office reports that the Senate bill will reduce the federal deficit by $81 billion over the first 10 years. But those numbers have been disputed by opponents of the legislation. For instance, Joseph Antos, a scholar with the American Enterprise Institute for Public Policy, argues that the favorable budget score is based on some creative deferrals of anticipated spending, not to mention massive cuts to Medicare providers that Congress is likely to override. Antos predicts the bill will add as much as $376 billion to the federal deficit through 2019. Meanwhile, lawmakers have a history of severely underselling the true costs of entitlement programs. According to the Wall Street Journal, when Medicaid was launched, the House Ways and Means Committee estimated that its first-year costs would be $238 million, but instead they surpassed $1 billion, and the program now costs 37 times more than it did when it was created, after adjusting for inflation. Its current cost of $251 billion is a $50 billion increase over last year alone. Similarly, when Medicare was created in 1965, Congressional budget officials said the cost would rise to only $12 billion in 1990, but its actual price tag when the ’90s rolled around was $90 billion — more than a sevenfold miscalculation. Since its inception, the rate of increase in annual Medicare spending has outpaced inflation almost every year, and a program that started at $4 billion now costs $428 billion annually. There are other examples, such as the 1988 Medicare home-care benefit that was supposed to cost $4 billion by 1993, and actually rose to $10 billion. There are a few exceptions as well, such as the 2003 Medicare prescription drug bill, which currently costs about one-third of original projections because of lower-than-anticipated participation and unforeseen savings from generic drugs. Despite uncertainty over cost, the leadership of the American Hospital Assoc. has lined up behind Obama’s efforts, with president and CEO Rich Umbdenstock calling for not only expanded health insurance coverage, but a simultaneous change in delivery systems that allows physicians and hospitals to better coordinate care and promote prevention and wellness — a concept at the center of Massachusetts’ move toward accountable care organizations (more on that later). “Every day, hospitals and caregivers are on the front lines in providing care to all Americans, regardless of whether they have insurance. Without health coverage, patients are less likely to receive the preventive care that could keep them well,” Umbdenstock noted in a statement. “Patients are showing up in hospital emergency rooms sicker and with more chronic conditions than ever before. That is why hospitals have stepped forward America’s hospitals stand ready to do our part to to be part of the solution. extend coverage to more Americans and to continually strive toward providing high-quality care for patients that is more efficient and affordable.” He did, however, express hope that stronger action be taken by lawmakers to reform the medical liability system and “rein in excessive lawsuits that are currently driving physicians to practice defensive medicine and raise the cost of care for everyone.” Proponents of malpractice reform note that the additional tests that arise from defensive medicine run counter to current efforts to streamline care and make it less expensive for everyone. Being Accountable Earlier this year, the state-appointed Special Commission on the Health Care Payment System proposed a sweeping health-payment reform for Massachusetts that centers on the concept of accountable care organizations (ACOs), each of which would include doctors, other community-based providers, and hospitals working together to collectively provide a full range of services for each patient. The ACO would take responsibility for caring for a patient for the year and, in exchange, accept some form of payment from the insurer. The system is geared toward controlling costs because it provides a one-time payment regardless of how many tests, procedures, and hospital admissions a patient requires, theoretically leading to greater efficiency and consolidation of services. However, some anxiety permeates the discussion of ACOs in Massachusetts. As Dr. Mario Motta, president of the Mass. Medical Society (MMS), recently testified on Beacon Hill, if the state institutes a payment system that’s never been tried elsewhere, he wants it done carefully and deliberately. Specifically, he promoted the use of small pilot programs at first. “We need to uncover the unintended consequences, learn from mistakes, and adjust, before it’s rolled out to larger sectors of our population,” he said. Meanwhile, Dr. Alice Coombs, president-elect of the MMS and the only physician member of the state’s payment reform commission, conceded that the health care system in Massachusetts is too diverse to impose a single solution on everyone and that the differences in specialties, physician practices across the state, economic conditions, and even patients must be considered. “Our physicians are telling us that one size does not fit all,” she said. Hospitals looking for ways to thrive under a changing reimbursement system can take heart that efforts across the country to improve quality of care — a much-touted watchword in Pioneer Valley hospitals — actually lead to a corresponding drop in costs. Take Pennsylvania, for example, where for the past 20 years a state agency has published medical outcomes, like death and complication rates, from various surgeries and treatments at hospitals. In doing so, it has uncovered stark connections between quality of care and lowered costs, mainly as a result of keeping readmission rates down. That, again, reflects the feeling of reform proponents that, if virtually all Americans are insured and encouraged to partake in regular and preventative care, they will be generally healthier, and their lifetime health costs will drop — and so will those of hospitals accustomed to treating poor and uninsured patients in the ER at great cost. To that end, the Senate bill under discussion includes $75 million annually for the U.S. Department of Health and Human Services to develop methods of improving quality, including possibly publishing outcomes. To further promote transparency, the HHS created the Hospital Compare Web site (www.hospitalcompare.hhs.gov), that breaks down how effectively hospitals are avoiding hospital-caused injuries and death, reducing infection, properly treating stroke and heart-attack victims, and performing in dozens of other categories. According to that site, “Mercy Medical Center has costs that are lower than many other providers in the region, and quality score outcomes that in many areas are higher,” said Mark Fulco, the hospital’s vice president of Strategy and Marketing. “Insurers and payers are starting to utilize this information to make their decisions, and prefer their members to be treated by hospitals that have proven cost savings and shown to eliminate unnecessary complications. We’re extremely progressive in our approach to changing the model of practice and making patient care as effective and low-cost as possible.” It’s a shift that had to happen, Fulco explained, because until now, there hasn’t been enough public recognition of the actual cost of health care — and how much it’s rising under the current private-insurance system. “There hasn’t been price sensitivity,” he said. “But as the consumer is bearing more and more of the cost of health insurance and health care, we’re seeing a dramatic shift in price sensitivity.” Bottom Line Meanwhile, hospitals are left to wonder, amid their own internal quality and efficiency improvements, how a surge of newly insured patients will affect their bottom line. “If we have 15% on the national level without insurance and we provide them with insurance, that’s more opportunities for hospitals to get paid,” Keenan said. “Now, if everyone in Massachusetts has insurance anyway, if federal payments are reduced, we’re not going to get that back in insurance because everyone’s already insured. So that’s a concern. On the positive side, we’re well-represented in this debate by our Congressional delegation, and our concerns will be heard.” Expect the conversation to be lively. © Copyright Health Care News
Is Your Home's Air Unhealthy
  Is Your Home's Air Unhealthy? Try Plants Plants Can Remove Harmful Indoor Airborne Contaminants, Study Says By Bill Hendrick WebMD Health News Reviewed by Louise Chang, MD Dec. 4, 2009 -- Certain plants can remove dangerous airborne contaminants commonly found in homes, new research suggests. The contaminants plants can remove from the air include harmful volatile organic compounds such as benzene, toluene, octane, alpha-pinene, and trichloroethylene (TCE), the researchers say in a study published in the August issue of HortScience. Of 28 indoor plants tested, Stanley Kays, PhD, of the University of Georgia and his horticultural team identified five “super ornamentals” that had the highest rates of contaminant removal, a process called phytoremediation. These are the red ivy (Hemigraphis alternata), English ivy (Hedera helix), variegated wax plant (Hoya cornosa), asparagus fern (Asparagus densiflorus), and the purple heart (Tradescantia pallida), the study says. The scientists placed the plants in glass, gas-tight containers, exposing them to common volatile organic compounds found indoors. And the plants did a good job of removing the airborne contaminants. Researchers say there may be thousands of plants capable of removing airborne contaminants. Volatile organic compounds are likely wafting about in every house, Kays tells WebMD. They’re given off by home furnishings, carpets, plastics, cleaning products, building materials such as drywall, paint, solvents, adhesives, and even tap water, Kays says. The pollutants have been linked to many illnesses, including asthma, cancer, and reproductive and neurological disorders, and claim 1.6 million lives a year, he says, attributing that number to the World Health Organization. Air inside homes and offices is often a concentrated source of such pollutants, in some cases up to 100 times more polluted than outdoor air, Kays tells WebMD. No one yet knows why some plants are effective at remediation, but he and other scientists are digging for answers. “We also want to determine the species and number of plants needed in a house or office to neutralize problem contaminants,” he says in a news release. “The idea that plants take up volatile compounds isn’t as much of a surprise as the poor air quality we measured inside some of the homes we tested.” There is no affordable way for average consumers to determine the air quality of their homes, Kays says. He tells WebMD that not all volatile organic compounds are toxic, and that some plants emit toxins, too. But placing some common ornamentals indoors has the potential to improve air quality, he says. “In reality, you are much more in danger from these compounds inside than outside,” he tells WebMD. “All houses have these compounds. Even computers give them off. It would be advantageous then to have a few plants in your house. They also keep humidity at fairly constant levels.” But there is no magic list on the horizon, he says. “You might have some plants that are good with benzenes but not with formaldehyde, which comes from upholstery, carpet, a lot of sources,” he tells WebMD. Hopefully, he says, in a few years there will be an affordable test that can alert people to the contaminants in their homes, and a list of the best plants to help clean the air. “Ideally, we’d have an extension service that would send out a packet that would do the test for you to send back and get recommendations,” he tells WebMD. He says scientists in Korea are “substantially ahead of us in phytoremediation research,” and one with whom he is collaborating, Kwang Jin Kim, PhD, of the National Horticultural Institute in Seoul, has evaluated the ability of 86 species to remove indoor formaldehyde. Poor Outcomes Reported For CCI Patients Leaving Hospitals On Ventilators By Susan Griffith Case Western Reserve University Dec. 5, 2009 Patients, discharged from hospitals on ventilator support and with cognitive impairments, fare poorly four months later. Researchers from the Frances Payne Bolton School of Nursing at Case Western Reserve University report these findings in American Journal of Critical Care. "Survival alone is not the only important outcome for patients," says Barbara Daly, the lead researcher on the National Institutes of Health-funded study, "Composite Outcomes of Chronically Critically Ill Patients 4 Months after Hospital Discharge." She adds that having a better quality of life by living at home, breathing free from the ventilator and having normal cognitive function are also important factors constituting a positive outcome in the aftermath of a hospital stay. The researchers studied chronically critically ill (CCI) patients, who are those who have survived a life-threatening illness but remain dependent on the high-technology services of a critical care unit. These patients had stays of longer than one week in the intensive care unit and spent more than three days on ventilator support. Following 257 patients at two and four months after their hospital stays, researchers found that 112 (43.6%) had what they categorized as "better" outcomes (living at home, able to breathe independently, with normal cognitive functioning). The 159 patients who were functioning without any cognitive impairment at the time of hospital discharge had better outcomes, with 111 (69.8%) breathing without the ventilator at home by 4 months. But the results for the 39 patients who required ventilator support at discharge were less encouraging; only one patient had achieved a "better" outcome. Of the study's 98 patients who had cognitive impairments at discharge, 29 (30%) recovered for a better outcome. A worse outcome is considered losing cognitive functioning, breathing on ventilator and living in a care facility. Little has been known about what happens after CCI patients leave the hospital, says Daly, the nursing school's Gertrude Perkins Olivia Professor of Oncology Nursing and clinical ethics director at University Hospitals Case Medical Center. "We believe that knowledge of exactly how rare 'better' outcomes are for those patients who are cognitively impaired and ventilator dependent at discharge is important information for ICU clinicians who are counseling families about treatment decisions," write the researchers. In a past survey about ICU communications, family members raised concerns about not being informed about the long-term consequences of their family member's illness. Helping doctors and nurses with information about the quality of life following the discharge, can help the medical professionals in care planning and informing family members about outcomes in the months to come. Other contributors to the study are Associate Professors Sara Douglas and Patricia Higgins and Assistant Professor Carol Kelly and Professors Nahida H. Gordon, Elizabeth O'Toole and Hugo Montenegro from Case Western Reserve University.
A Comparison of Senate, House Bills
  A Comparison Of House, Senate Health Care Bills 12/26/2009 By RICARDO ALONSO-ZALDIVAR and ERICA WERNERAP The Senate Democratic bill (Patient Protection and Affordable Care Act): WHO'S COVERED: About 94 percent of legal residents under age 65 — compared with 83 percent now. Government subsidies to help buy coverage start in 2014. Of the remaining 24 million people under age 65 left uninsured, about one-third would be illegal immigrants. COST: Coverage provisions cost $871 billion over 10 years. HOW IT'S PAID FOR: Fees on insurance companies, drugmakers, medical device manufacturers. Medicare payroll tax increased to 2.35 percent on income over $200,000 a year for individuals, $250,000 for couples. A 10 percent sales tax on tanning salons, to be paid by the person soaking up the rays. Cuts to Medicare and Medicaid. Forty percent excise tax on insurance companies, keyed to premiums paid on health care plans costing more than $8,500 annually for individuals and $23,000 for families. Fees for employers whose workers receive government subsidies to help them pay premiums. Fines on people who fail to purchase coverage. REQUIREMENTS FOR INDIVIDUALS: Almost everyone must get coverage through an employer, on their own or through a government plan. Exemptions for economic hardship. Those who are obligated to buy coverage and refuse to do so would pay a fine starting at $95 in 2014 and rising to $750. REQUIREMENTS FOR EMPLOYERS: Not required to offer coverage, but companies with more than 50 employees would pay a fee of $750 per employee if the government ends up subsidizing employees' coverage. SUBSIDIES: Tax credits for individuals and families likely making up to 400 percent of the federal poverty level, which computes to $88,200 for a family of four. Tax credits for small employers. BENEFITS PACKAGE: All plans sold to individuals and small businesses would have to cover basic benefits. The government would set four levels of coverage. The least generous would pay an estimated 60 percent of health care costs per year; the most generous would cover an estimated 90 percent. INSURANCE INDUSTRY RESTRICTIONS: Starting in 2014: no denial of coverage based on pre-existing conditions. No higher premiums allowed for pre-existing conditions or gender. Limits on higher premiums based on age and family size. Starting upon enactment of legislation: children up to age 26 can stay on parents insurance; no lifetime limits on coverage. GOVERNMENT-RUN PLAN: In place of a government-run insurance option, the estimated 26 million Americans purchasing coverage through new insurance exchanges would have the option of signing up for national plans overseen by the same office that manages health coverage for federal employees and members of Congress. Those plans would be privately owned, but one of them would have to be operated on a nonprofit basis, as many Blue Cross Blue Shield plans are now. HOW YOU CHOOSE YOUR HEALTH INSURANCE: Self-employed people, uninsured individuals and small businesses could pick a plan offered through new state-based purchasing pools. Would generally encourage employees to keep work-provided coverage. DRUGS: Grants 12 years of market protection to high-tech drugs used to combat cancer, Parkinson's and other deadly diseases. Drug companies contribute $80 billion over 10 years with the majority of the money used to limit the prescription coverage gap in Medicare. CHANGES TO MEDICAID: Income eligibility levels likely to be standardized to 133 percent of poverty — $29,327 a year for a family of four — for parents, children and pregnant women. Federal government would pick up the full cost of the expansion during the first three years. States could negotiate with insurers to arrange coverage for people with incomes slightly higher than the cutoff for Medicaid. LONG-TERM CARE: New voluntary long-term care insurance program would provide a basic benefit designed to help seniors and disabled people avoid going into nursing homes. ANTITRUST: Maintains the health insurance industry's decades-old antitrust exemption. ILLEGAL IMMIGRANTS: Would be barred from receiving government subsidies or using their own money to buy coverage offered by private companies in the exchanges. ABORTION: The bill tries to maintain a strict separation between taxpayer funds and private premiums that would pay for abortion coverage. No health plan would be required to offer coverage for the procedure. In plans that do cover abortion, beneficiaries would have to pay for it separately, and those funds would have to be kept in a separate account from taxpayer money. Moreover, individual states would be able to prohibit abortion coverage in plans offered through the exchange, after passing specific legislation to that effect. Exceptions would be made for cases of rape, incest and danger to the life of the mother. — The House bill (Affordable Health Care for America Act): WHO'S COVERED: About 96 percent of legal residents under age 65 — compared with 83 percent now. Government subsidies to help buy coverage start in 2013. About one-third of the remaining 18 million people under age 65 left uninsured would be illegal immigrants. COST: The Congressional Budget Office says the bill's cost of expanding insurance coverage over 10 years is $1.055 trillion. The net cost is $894 billion, factoring in penalties on individuals and employers who don't comply with new requirements. That's under President Barack Obama's $900 billion goal. However, those figures leave out a variety of new costs in the bill, including increased prescription drug coverage for seniors under Medicare, so the measure may be around $1.2 trillion. HOW IT'S PAID FOR: $460 billion over the next decade from new income taxes on single people making more than $500,000 a year and couples making more than $1 million. The original House bill taxed individuals making $280,000 a year and couples making more than $350,000, but the threshold was increased in response to lawmakers' concerns that the taxes would hit too many people and small businesses. There are also more than $400 billion in cuts to Medicare and Medicaid; a new $20 billion fee on medical device makers; $13 billion from limiting contributions to flexible spending accounts; sizable penalties paid by individuals and employers who don't obtain coverage; and a mix of other corporate taxes and fees. REQUIREMENTS FOR INDIVIDUALS: Individuals must have insurance, enforced through a tax penalty of 2.5 percent of income. People can apply for hardship waivers if coverage is unaffordable. REQUIREMENTS FOR EMPLOYERS: Employers must provide insurance to their employees or pay a penalty of 8 percent of payroll. Companies with payrolls under $500,000 annually are exempt — a change from the original $250,000 level to accommodate concerns of moderate Democrats — and the penalty is phased in for companies with payrolls between $500,000 and $750,000. Small businesses — those with 10 or fewer workers — get tax credits to help them provide coverage. SUBSIDIES: Individuals and families with annual income up to 400 percent of poverty level, or $88,000 for a family of four, would get sliding-scale subsidies to help them buy coverage. The subsidies would begin in 2013. HOW YOU CHOOSE YOUR HEALTH INSURANCE: Beginning in 2013, through a new Health Insurance Exchange open to individuals and, initially, small employers. It could be expanded to large employers over time. States could opt to operate their own exchanges in place of the national exchange if they follow federal rules. BENEFITS PACKAGE: A committee would recommend a so-called essential benefits package including preventive services. Out-of-pocket costs would be capped. The new benefit package would be the basic benefit package offered in the exchange. INSURANCE INDUSTRY RESTRICTIONS: Starting in 2013, no denial of coverage based on pre-existing conditions. No higher premiums allowed for pre-existing conditions or gender. Limits on higher premiums based on age. GOVERNMENT-RUN PLAN: A new public plan available through the insurance exchanges would be set up and run by the health and human services secretary. Democrats originally designed the plan to pay Medicare rates plus 5 percent to doctors. But the final version — preferred by moderate lawmakers — would let the HHS secretary negotiate rates with providers. CHANGES TO MEDICAID: The federal-state insurance program for the poor would be expanded to cover all individuals under age 65 with incomes up to 150 percent of the federal poverty level, which is $33,075 per year for a family of four. The federal government would pick up the full cost of the expansion in 2013 and 2014; thereafter the federal government would pay 91 percent and states would pay 9 percent. DRUGS: Grants 12 years of market protection to high-tech drugs used to combat cancer, Parkinson's and other deadly diseases. Phases out the gap in Medicare prescription drug coverage by 2019. Requires the HHS secretary to negotiate drug prices on behalf of Medicare beneficiaries. LONG-TERM CARE: New voluntary long-term care insurance program would provide a basic benefit designed to help seniors and disabled people avoid going into nursing homes. ANTITRUST: Would strip the health insurance industry of a long-standing exemption from antitrust laws covering market allocation, price-fixing and bid rigging. The bill also would give the Federal Trade Commission authority to look into the health insurance industry at its own initiative. ILLEGAL IMMIGRANTS: Would be barred from receiving government subsidies but permitted to use their own money to buy coverage offered by private companies in the exchange. ABORTION: Private companies in the exchange could not offer plans covering abortion if those plans received federal subsidy money. Most plans in the exchange would be affected, because most consumers in the exchange would be using federal subsidy money to buy coverage. The new government plan could not offer abortion coverage. Insurance companies would be permitted to offer supplemental abortion coverage in separate plans that people could buy with their own money. Use of federal money for abortion coverage would be limited to cases of rape, incest or danger to the woman's life. Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
New Diabetes Drug
  New Diabetes Drug Victoza Approved Victoza Is a Once-Daily Injection for Adults With Type 2 Diabetes By Miranda Hitti WebMD Health News Reviewed by Louise Chang, MD Jan. 26, 2010 The FDA has approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in adults. Victoza is intended to help lower blood sugar levels along with diet, exercise, and selected other diabetes medicines. It isn't recommended as the first therapy patients try if they haven't adequately controlled their diabetes with diet and exercise alone. Victoza belongs to a class of medicines known as glucagon-like peptide-1 (GLP-1) receptor agonists, which help the pancreas make more insulin after eating a meal. “Diabetes is a leading cause of death and disability, with more than 1.5 million new cases diagnosed annually,” says Mary Parks, MD, director of the division of metabolism and endocrinology products at the FDA. “Controlling blood sugar levels is very important to preventing or reducing the long term complications of diabetes, and Victoza offers certain patients with type 2 diabetes a treatment option for controlling their blood glucose levels," Parks says. FDA's Victoza Decision The FDA approved Victoza based on five clinical trials involving more than 3,900 people. In those trials, pancreatitis (inflammation of the pancreas) occurred more often in patients who took Victoza than in patients taking other diabetes medicines. The FDA states that Victoza should be stopped if patients experience severe abdominal pain, with or without nausea and vomiting, and should not be restarted if blood tests confirm that they have pancreatitis. Victoza should be used with caution in people with a history of pancreatitis, according to the FDA. The most common side effects observed with Victoza in the clinical trials were headache, nausea, and diarrhea. Other side effects included allergic-like reactions such as hives. In its clinical trials, Victoza was not linked to an increased risk of cardiovascular events -- including heart attack, stroke, and death caused by heart disease -- in people who were mainly at low risk for such events. In keeping with FDA policy, Victoza will be studied further to check its cardiovascular safety in higher-risk groups. Other postmarketing studies will evaluate the risk of thyroid cancer and other cancer risks, as well as the risks of seriously low blood glucose levels ( hypoglycemia), pancreatitis, and allergic reactions. The FDA notes that in animal studies, Victoza caused tumors of the thyroid gland in rats and mice. Some of those tumors were cancers, which were more likely in rats that got doses of Victoza that were eight times higher than what people would receive. It's not known if Victoza could cause thyroid tumors or a very rare type of thyroid cancer called medullary thyroid cancer in people. For that reason, the FDA says Victoza should not be used as the first treatment for diabetes until more studies are done. Victoza should not be used in people who are already at risk for medullary thyroid cancer, such as those who have medullary thyroid cancer in the family, or those with a rare genetic condition called multiple endocrine neoplasia syndrome type 2. Victoza has a risk evaluation and mitigation strategy to help patients and health-care providers understand the drug's risks and to ensure that the drug's benefits outweigh the risk of acute pancreatitis and the potential risk of medullary thyroid cancer. Victoza is made by the drug company Novo Nordisk. The launch price of the 1.2-milligram dose will be $8.03 a day.
Healthy Communication
  Healthy communication between patients and physicians reduces medical errors March 2010 Consider this: 195,000 people die each year from preventable medical errors. But, studies show clear and open communication between patients and their physicians can go a long way toward reducing the number of medical mistakes. National Patient Safety Awareness Week is taking place from March 7th to the 13th. This year’s theme is all about healthy communication between patients and their physicians. The simple theme Let’s Talk: Healthy Conversations for Safer Healthcare is aimed at helping people become more involved in their own health care. So, how can consumers get proactive about their health? The number one way is by becoming more informed about their health and being a part of every decision that’s made about their health care. The following tips provide simple ways to open up the lines of communication with physicians, leading to better quality, safer health care. Read on for more tips: What is the medicine for? How am I supposed to take it and for how long? What side effects are likely? What do I do if they occur? Is this medicine safe to take with other medicines or dietary supplements I am taking? What food, drink, or activities should I avoid while taking this medicine? To read more tips for preventing medical errors, visit: http://www.ahrq.gov/CONSUMER/20tips.htm. For more information about National Patient Safety Awareness Week, visit http://www.npsf.org/hp/psaw/. Aetna Study Shows PHR Usage Connected to Safer, Higher Quality Health Care A study of consumers who actively use a PHR underscores the fact that people who are involved in their own health care see better results. Aetna’s PHR contains information gathered from across the health care spectrum – such as physician offices, labs, diagnostic treatments and pharmacies. That information is combined with user-entered information such as family health history, over-the-counter medications or allergies. All of this information is continuously scanned by patented technology called the CareEngine to identify potential gaps in care. Members can access their information and share it with their physicians through Aetna’s secure member website. The Aetna study looked at people who used their PHR at least four times and found that PHR users: Received 57 percent more Care Considerations, which are alerts sent to members and physicians when the CareEngine identifies a gap in care, compared to non PHR users; and Resolved 68 percent more Care Considerations than non PHR users. The study also found that Care Considerations generated by self-reported information are six times higher for PHR users compared to the non-user group. This shows that members who use their PHR are receiving more information about the ways they can work with their physicians to improve their health. Did you know? Approximately 1.3 million people are injured annually in the United States following so-called "medication errors." (Health Grades, 2004) The Institute of Medicine estimates that medical errors cost the U.S. approximately $37.6 billion each year and about $17 billion of those costs are associated with preventable errors. The RAND Institute estimates that health information technology could save the U.S. health care system approximately $100 billion over 10 years by digitizing patient health records and housing them in a central online location. Three Ways a PHR Fosters Safer, Higher Quality Health Care 1.) More information leads to better care. Not only does the PHR have members’ claims data automatically loaded into it, but members can also add information such as family history, over-the-counter medicines and allergies. This health information is available to members online. Members have the option of sharing it with their physicians leading to more productive visits at the doctors’ office. 2.) Keeping track of prescriptions and doctors' visits keeps people on track for better health. The more information that is available, the more likely people are to follow their physicians’ advice, such as finishing antibiotics or sticking to a recommended diet. Plus, people who regularly use a PHR may also save money. If doctors know about previous tests and lab results, they can avoid unnecessary or duplicate tests. More importantly, they can provide better care, since information like past medications and allergies is available through the PHR. 3) Access to personal health information anywhere, anytime. A PHR can be helpful to people when they are away from home – whether they are traveling around the globe or displaced from home after a natural disaster. With a PHR, patients’ health information is available online for them and their doctors 24 hours a day, 7 days a week. PRODUCT SPOTLIGHT: AETNA’S FLEXIBLE SPENDING ACCOUNTS Millions of Americans enroll in health care Flexible Spending Accounts (FSA) to put aside pretax dollars to pay for eligible out of pocket health care expenses. But a surprising amount of people don’t spend all of the money by the end of the year. If the money isn’t used, employers can’t give it back. But there is good news – the Internal Revenue Service (IRS) allows employers to give employees a grace period of up to two and a half months from the end of the FSA plan year – for plans ending December 31, 2009, they may have until March 15, 2010 – to spend unused money in their FSAs. In addition, most employers allow employees 90 days after the end of the plan year to submit receipts for costs incurred in the previous year. Health care FSAs can be used for copays and deductibles, dental work, hearing aids, laboratory fees and prescription drugs. In addition, the IRS allows FSA funds to be used for: 1. Orthodontia 2. Chiropractic treatments 3. Acupuncture and physical therapy 4. Mental health counseling sessions 5. Over-the-counter items like pain relievers, antacids and sunscreen (SPF 30 or higher) 6. Vaporizers and thermometers 7. Prescription eyeglasses and sunglasses, contact lenses and contact lens solution 8. Mileage and travel expenses for a doctors visit or hospital stay 9. Fertility treatments 10. Childbirth classes SOURCE Aetna
Caring for Aging Parents
  Caring for aging parents? Where to find help (ARA) - As your parents age, are you worried about their safety living on their own, or your ability to physically care for them while trying to maintain your family, work and social life? It's a problem faced by more than 26 million Americans who care for elderly parents, relatives or friends, and many don't know where to turn to for help. Take the case of Beverly, whose mother started developing short-term memory loss. At first, Beverly considered it a normal, though unfortunate, part of growing older. But as the weeks and months progressed, her mom's memory loss worsened. "My father would bring it up with me," she says. "He would say, 'Mom's losing her memory. She can't focus on anything. It's getting really difficult.'" Eventually, Beverly decided to begin the search for an assisted living home for her mom, and a nearby apartment for her dad. "I looked in the Yellow Pages, drove around to a few places, but nothing seemed like something we'd be happy with. It felt like [trying to find] a needle in a haystack." Like so many thousands of confused and overwhelmed care-seekers, Beverly contacted A Place For Mom, a free eldercare referral service. Beverly was then connected to Maggie, an Eldercare Advisor. "It was like all of a sudden someone was going to listen and help me find a solution," says Beverly. Maggie helped Beverly narrow down her search to senior housing properties where her mother could be cared for 24 hours a day, while her father could live nearby and remain independent. "When we talked on the phone, I could tell she was stressed," says the Eldercare Advisor. "She knew what she was looking for, but didn't know how to find it or where to start. I told her, 'I can save you valuable time and stress.'" Maggie referred Beverly to a place that met both parents' needs. For her mother, Beverly chose an assisted living home that offered specialized dementia care. And just across the lawn was a senior apartment community perfect for her father. When Beverly brought him to tour both facilities, she saw something she hadn't in a long time -- his smile. "This is perfect -- exactly what we want," her father says. "I love it; let's do this." The couple moved in to their new homes in April, 2006, and Beverly takes comfort in knowing they are safe -- and happy. "A Place For Mom was absolutely amazing. It was the best thing for everyone," she says. "Don't be afraid to ask for help. Know that it will get better. When you're in the middle of it, it can be so overwhelming. But, with the right help, it can -- and does -- get better." Save time and energy researching options for your parent's care. Visit www.aplaceformom.com to find the programs and homes near you with background information on their specialties. Sponsored content provided by ARALifestyle. Copyright ARAnet, Inc.
Caring For An Elderly, Sick Spouse
  Caring For An Elderly, Sick Spouse Sometimes Has Positive Elements Patricia Donovan University at Buffalo 23 Jun 2010 Although long-term care of sick or disabled loved ones is widely recognized as a threat to the caregiver's health and quality of life, a new study led by University at Buffalo psychologist Michael Poulin, PhD, finds that in some contexts, helping valued loved ones may promote the well being of helpers. "Does a Helping Hand Mean a Heavy Heart?," published in the journal Psychology and Aging (2010, Vol. 25., No. 1), reports on a study by Poulin and five co-authors from the University of Michigan Department of Internal Medicine, which closely analyzed helping behavior and well-being among 73 spousal caregivers, many of them elderly. Poulin, an assistant professor of psychology, says the study team wanted to learn if there were some positive aspects of caregiving, aspects that did not provoke the burnout, high stress and poor health associated with being a caregiver. If so, they wanted to know why these aspects had a positive effect. They learned that despite the burdensome nature of their role, caregivers experience more positive emotions and fewer negative emotions when they engage in "active care" like feeding, bathing, toileting and otherwise physically caring for the spouse. "Our data don't tell us exactly what psychological processes are responsible," he says, "but we hypothesize that people may be hardwired so that actively attending to the concrete needs and feelings of others reduces our personal anxiety." The study found that passive care, on the other hand, which requires the spouse to simply be nearby in case anything should go wrong, provokes negative emotions in the caretaker, and leads to fewer positive emotions. The study involved 73 subjects (mean age was 71.5 years, age range was 35-89 years) who were providing full-time home care to an ailing spouse. Participants carried Palm Pilots that beeped randomly to signal them to report how much time they had spent actively helping and/or being on call since the last beep, the activities they actually engaged in and their emotional state at that moment. The researchers found no moderating effects of age on the association between helping and well-being. In other words, helping predicted positive and negative effects similarly for adults of all ages. One variable that did affect outcome was the level of perceived interdependence with the spouse experienced by the caregiver -- that is, the extent to which caregivers viewed themselves as sharing a mutually beneficial relationship with their spouse. "For interdependent couples, the positive effects of active care were particularly strong," Poulin says, adding that this outcome supports the prediction that "individuals should derive the greatest satisfaction out of helping those with whom they perceive a shared physical or emotional fate." Poulin says study findings have broad implications for research on caregiving and for research on helping behavior more generally, especially in the aging context. "Overall," he says, "we wouldn't say that caring for an ailing loved one is going to be good for you or healthy for you, but certain activities may be beneficial, especially in high-quality relationships." Researchers and social scientists want government or other agencies to provide respite for caregivers, which would be a good thing, Poulin says, "but as this study demonstrates, it is extremely important that caretakers receive the right kind of relief at the right time -- perhaps less time off from active care duties, and more time off from the onerous task of passively monitoring an ailing loved one." Article URL: http://www.medicalnewstoday.com/articles/192688.php Compassionate Health Care And Better Teamwork Encouraged By Schwartz Center Rounds Vicki Ritterband Kenneth B. Schwartz Center 08 Jul 2010 Caregivers who participated in a program where attendees discuss medical cases that were complex for psychosocial and emotional reasons were more likely to be attentive to the psychosocial and emotional aspects of patient care. The program also enhanced their beliefs about the importance of empathy. These were a couple of the most significant findings of a study that recently appeared in Academic Medicine. The study looked at the effects of Schwartz Center Rounds - case-based facilitated discussions at which caregivers discuss the psychosocial and emotional challenges of their jobs. Held at 195 health care facilities in 31 states, the Rounds provide a safe and confidential forum where clinicians share their job-related experiences, fears, dilemmas, joys and concerns with one another. The researchers conducted retrospective surveys of attendees at six sites offering Schwartz Center Rounds for at least three years and prospective surveys of attendees at 10 Rounds sites before the program began and after at least seven Rounds sessions were conducted. "We know that good caregiver-patient relationships, communication and "whole-person" knowledge of patients have been correlated with improvements in clinical and functional status, adherence, patient trust and reduced malpractice suits," said lead author Beth A. Lown, MD, a faculty member at Mt. Auburn Hospital and an assistant professor of medicine at Harvard Medical School. "The Rounds foster deeper, more meaningful relationships with patients, yielding significant benefits for everyone involved." Respondents to the retrospective survey also reported: • Better teamwork, including greater appreciation of the roles and contributions of colleagues • Decreases in perceived stress • Improvements in the ability to cope with the psychosocial demands and emotional difficulties of care "The finding that the Rounds encourage better teamwork should be very intriguing to anyone interested in care quality because collaboration plays an important role in the causation and prevention of adverse events," said Dr. Lown. Researchers also reported that for participants in the prospective survey of newer Rounds hospitals, the greater the number of Rounds attended, the greater: • the impact on that caregiver's insights into the psychosocial aspects of care • their focus on the effects of illness on patients' lives and families • their level of compassion The study also revealed that Rounds benefit departments and hospitals as a whole, particularly by encouraging a culture of teamwork. Rounds have spurred programmatic changes at host hospitals, including greater use of palliative care teams and changes in nursing care in the ICU. The study's co-author is Colleen F. Manning, director of research at Goodman Research Group, Inc. Article URL: http://www.medicalnewstoday.com/articles/194107.php


Clicking "SUBMIT" you agree with our "Terms & Conditions"

 


We recommend that your password should be at least 5 characters long and should be different from your username. Your e-mail address must be valid. We use e-mail for communication purposes (order notifications, etc). Therefore, it is essential to provide a valid e-mail address to be able to use our services correctly.

All your private data is confidential. We will never sell, exchange or market it in any way. For further information on the responsibilities of both parts, you may refer to our:

Terms & Conditions 
 
 
      Users online
  
3 unregistered customer(s)


      Your cart
  
Cart is empty

 View cart
 Checkout
 Wish list
 Orders history


      Authentication
  
Username:    
Password:    

Log in
 
Register
Recover password

If Javascript is enabled in your browser click here


      News
  

Caring For An Elderly, Sick Spouse Sometimes Has Positive Elements
 
Patricia Donovan
University at Buffalo
23 Jun 2010
 
Although long-term care of sick or disabled loved ones is widely recognized as a threat to the caregiver's health and quality of life, a new study led by University at Buffalo psychologist Michael Poulin, PhD, finds that in some contexts, helping valued loved ones may promote the well being of helpers.
 
"Does a Helping Hand Mean a Heavy Heart?," published in the journal Psychology and Aging (2010, Vol. 25., No. 1), reports on a study by Poulin and five co-authors from the University of Michigan Department of Internal Medicine, which closely analyzed helping behavior and well-being among 73 spousal caregivers, many of them elderly.
 
Poulin, an assistant professor of psychology, says the study team wanted to learn if there were some positive aspects of caregiving, aspects that did not provoke the burnout, high stress and poor health associated with being a caregiver. If so, they wanted to know why these aspects had a positive effect.
 
They learned that despite the burdensome nature of their role, caregivers experience more positive emotions and fewer negative emotions when they engage in "active care" like feeding, bathing, toileting and otherwise physically caring for the spouse.
 
"Our data don't tell us exactly what psychological processes are responsible," he says, "but we hypothesize that people may be hardwired so that actively attending to the concrete needs and feelings of others reduces our personal anxiety."
 
The study found that passive care, on the other hand, which requires the spouse to simply be nearby in case anything should go wrong, provokes negative emotions in the caretaker, and leads to fewer positive emotions.
 
The study involved 73 subjects (mean age was 71.5 years, age range was 35-89 years) who were providing full-time home care to an ailing spouse. Participants carried Palm Pilots that beeped randomly to signal them to report how much time they had spent actively helping and/or being on call since the last beep, the activities they actually engaged in and their emotional state at that moment.
 
The researchers found no moderating effects of age on the association between helping and well-being. In other words, helping predicted positive and negative effects similarly for adults of all ages. One variable that did affect outcome was the level of perceived interdependence with the spouse experienced by the caregiver -- that is, the extent to which caregivers viewed themselves as sharing a mutually beneficial relationship with their spouse.
 
"For interdependent couples, the positive effects of active care were particularly strong," Poulin says, adding that this outcome supports the prediction that "individuals should derive the greatest satisfaction out of helping those with whom they perceive a shared physical or emotional fate."
 
Poulin says study findings have broad implications for research on caregiving and for research on helping behavior more generally, especially in the aging context.
 
"Overall," he says, "we wouldn't say that caring for an ailing loved one is going to be good for you or healthy for you, but certain activities may be beneficial, especially in high-quality relationships."
 
Researchers and social scientists want government or other agencies to provide respite for caregivers, which would be a good thing, Poulin says, "but as this study demonstrates, it is extremely important that caretakers receive the right kind of relief at the right time -- perhaps less time off from active care duties, and more time off from the onerous task of passively monitoring an ailing loved one."
 
 
Compassionate Health Care And Better Teamwork Encouraged By Schwartz Center Rounds
 
Vicki Ritterband Kenneth B.
Schwartz Center
08 Jul 2010
 
Caregivers who participated in a program where attendees discuss medical cases that were complex for psychosocial and emotional reasons were more likely to be attentive to the psychosocial and emotional aspects of patient care. The program also enhanced their beliefs about the importance of empathy.
 
These were a couple of the most significant findings of a study that recently appeared in Academic Medicine. The study looked at the effects of Schwartz Center Rounds - case-based facilitated discussions at which caregivers discuss the psychosocial and emotional challenges of their jobs. Held at 195 health care facilities in 31 states, the Rounds provide a safe and confidential forum where clinicians share their job-related experiences, fears, dilemmas, joys and concerns with one another.
 
The researchers conducted retrospective surveys of attendees at six sites offering Schwartz Center Rounds for at least three years and prospective surveys of attendees at 10 Rounds sites before the program began and after at least seven Rounds sessions were conducted.
 
"We know that good caregiver-patient relationships, communication and "whole-person" knowledge of patients have been correlated with improvements in clinical and functional status, adherence, patient trust and reduced malpractice suits," said lead author Beth A. Lown, MD, a faculty member at Mt. Auburn Hospital and an assistant professor of medicine at Harvard Medical School. "The Rounds foster deeper, more meaningful relationships with patients, yielding significant benefits for everyone involved."
 
Respondents to the retrospective survey also reported:
 
• Better teamwork, including greater appreciation of the roles and contributions of colleagues
• Decreases in perceived stress
• Improvements in the ability to cope with the psychosocial demands and emotional difficulties of care
 
"The finding that the Rounds encourage better teamwork should be very intriguing to anyone interested in care quality because collaboration plays an important role in the causation and prevention of adverse events," said Dr. Lown. Researchers also reported that for participants in the prospective survey of newer Rounds hospitals, the greater the number of Rounds attended, the greater:
 
• the impact on that caregiver's insights into the psychosocial aspects of care
• their focus on the effects of illness on patients' lives and families
• their level of compassion
 
The study also revealed that Rounds benefit departments and hospitals as a whole, particularly by encouraging a culture of teamwork. Rounds have spurred programmatic changes at host hospitals, including greater use of palliative care teams and changes in nursing care in the ICU.
 
The study's co-author is Colleen F. Manning, director of research at Goodman Research Group, Inc.
 
Article URL: http://www.medicalnewstoday.com/articles/194107.php


Previous news

Your email:

Type the characters you see in the picture. (If you do not see any picture here, please enable images in your web browser options and refresh this page):

Subscribe



Provided by i5Networks.com internet business for sale Copyright © 2007-2010 Medical SupplyBiz